International Assets Investment Management LLC Buys New Stake in Chemed Co. (NYSE:CHE)

International Assets Investment Management LLC bought a new position in Chemed Co. (NYSE:CHE - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 73,701 shares of the company's stock, valued at approximately $430,970,000. International Assets Investment Management LLC owned about 0.49% of Chemed at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Fifth Third Bancorp grew its position in shares of Chemed by 0.5% during the 3rd quarter. Fifth Third Bancorp now owns 3,914 shares of the company's stock valued at $2,034,000 after acquiring an additional 21 shares during the period. Legacy Wealth Asset Management LLC grew its position in shares of Chemed by 0.9% during the 4th quarter. Legacy Wealth Asset Management LLC now owns 2,275 shares of the company's stock valued at $1,330,000 after acquiring an additional 21 shares during the period. Deutsche Bank AG grew its position in shares of Chemed by 0.5% during the 1st quarter. Deutsche Bank AG now owns 4,893 shares of the company's stock valued at $2,631,000 after acquiring an additional 22 shares during the period. Kestra Advisory Services LLC boosted its holdings in Chemed by 3.8% in the 3rd quarter. Kestra Advisory Services LLC now owns 634 shares of the company's stock worth $329,000 after buying an additional 23 shares during the last quarter. Finally, IHT Wealth Management LLC increased its stake in Chemed by 3.8% during the 2nd quarter. IHT Wealth Management LLC now owns 624 shares of the company's stock worth $338,000 after buying an additional 23 shares in the last quarter. Hedge funds and other institutional investors own 95.85% of the company's stock.

Analyst Ratings Changes

A number of equities analysts have commented on CHE shares. Oppenheimer increased their target price on Chemed from $625.00 to $650.00 and gave the company an "outperform" rating in a report on Thursday, February 29th. Royal Bank of Canada increased their price target on Chemed from $604.00 to $712.00 and gave the company an "outperform" rating in a report on Monday, March 4th.

Chemed Trading Up 0.1 %

Chemed stock traded up $0.94 during mid-day trading on Friday, hitting $630.26. The company's stock had a trading volume of 48,428 shares, compared to its average volume of 79,314. The firm has a market capitalization of $9.53 billion, a PE ratio of 35.17, a price-to-earnings-growth ratio of 2.54 and a beta of 0.42. Chemed Co. has a 1 year low of $492.84 and a 1 year high of $654.62. The stock's fifty day moving average is $618.37 and its two-hundred day moving average is $581.16.

Chemed (NYSE:CHE - Get Free Report) last issued its quarterly earnings data on Tuesday, February 27th. The company reported $6.60 earnings per share for the quarter, topping the consensus estimate of $6.25 by $0.35. Chemed had a return on equity of 32.29% and a net margin of 12.03%. The company had revenue of $585.90 million during the quarter, compared to analyst estimates of $586.64 million. During the same period in the prior year, the business posted $5.39 earnings per share. The firm's revenue for the quarter was up 7.2% compared to the same quarter last year. On average, equities analysts expect that Chemed Co. will post 21.99 EPS for the current fiscal year.

Chemed Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 15th. Stockholders of record on Monday, February 26th were given a dividend of $0.40 per share. The ex-dividend date of this dividend was Friday, February 23rd. This represents a $1.60 annualized dividend and a dividend yield of 0.25%. Chemed's dividend payout ratio is currently 8.93%.

Insider Transactions at Chemed

In other news, EVP Spencer S. Lee sold 2,000 shares of the firm's stock in a transaction on Thursday, March 28th. The stock was sold at an average price of $641.65, for a total transaction of $1,283,300.00. Following the completion of the transaction, the executive vice president now directly owns 20,760 shares in the company, valued at $13,320,654. The transaction was disclosed in a document filed with the SEC, which is available at this link. In other news, EVP Spencer S. Lee sold 2,000 shares of the stock in a transaction on Thursday, March 28th. The stock was sold at an average price of $641.65, for a total value of $1,283,300.00. Following the sale, the executive vice president now directly owns 20,760 shares in the company, valued at $13,320,654. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, VP Brian C. Judkins sold 11,158 shares of the stock in a transaction on Wednesday, March 20th. The shares were sold at an average price of $645.00, for a total value of $7,196,910.00. Following the completion of the sale, the vice president now owns 1,422 shares in the company, valued at $917,190. The disclosure for this sale can be found here. Insiders sold a total of 15,808 shares of company stock worth $10,184,531 over the last ninety days. Company insiders own 4.03% of the company's stock.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.